rs76776920

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_052867.4(NALCN):​c.2305C>T​(p.His769Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0251 in 1,613,804 control chromosomes in the GnomAD database, including 602 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H769Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.018 ( 22 hom., cov: 33)
Exomes 𝑓: 0.026 ( 580 hom. )

Consequence

NALCN
NM_052867.4 missense

Scores

2
6
9

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 9.36

Publications

11 publications found
Variant links:
Genes affected
NALCN (HGNC:19082): (sodium leak channel, non-selective) This gene encodes a voltage-independent, nonselective cation channel which belongs to a family of voltage-gated sodium and calcium channels that regulates the resting membrane potential and excitability of neurons. This family is expressed throughout the nervous system and conducts a persistent sodium leak current that contributes to tonic neuronal excitability. The encoded protein forms a channelosome complex that includes G-protein-coupled receptors, UNC-79, UNC-80, NCA localization factor-1, and src family tyrosine kinases. Naturally occurring mutations in this gene are associated with infantile neuroaxonal dystrophy, infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) syndrome, and congenital contractures of the limbs and face with hypotonia and developmental delay (CLIFAHDD) syndrome. A knockout of the orthologous gene in mice results in paralysis with a severely disrupted respiratory rhythm, and lethality within 24 hours after birth. [provided by RefSeq, Apr 2017]
NALCN Gene-Disease associations (from GenCC):
  • congenital contractures of the limbs and face, hypotonia, and developmental delay
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • hypotonia, infantile, with psychomotor retardation and characteristic facies 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • digitotalar dysmorphism
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Freeman-Sheldon syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Sheldon-hall syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypotonia, infantile, with psychomotor retardation and characteristic facies
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • temporal lobe epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the NALCN gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 63 curated pathogenic missense variants (we use a threshold of 10). The gene has 9 curated benign missense variants. Gene score misZ: 4.9555 (above the threshold of 3.09). Trascript score misZ: 6.7536 (above the threshold of 3.09). GenCC associations: The gene is linked to congenital contractures of the limbs and face, hypotonia, and developmental delay, temporal lobe epilepsy, hypotonia, infantile, with psychomotor retardation and characteristic facies 1, Sheldon-hall syndrome, digitotalar dysmorphism, hypotonia, infantile, with psychomotor retardation and characteristic facies, Freeman-Sheldon syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.0089760125).
BP6
Variant 13-101110678-G-A is Benign according to our data. Variant chr13-101110678-G-A is described in ClinVar as Benign. ClinVar VariationId is 262255.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0185 (2812/152276) while in subpopulation NFE AF = 0.0296 (2010/68016). AF 95% confidence interval is 0.0285. There are 22 homozygotes in GnomAd4. There are 1291 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 22 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NALCNNM_052867.4 linkc.2305C>T p.His769Tyr missense_variant Exon 20 of 44 ENST00000251127.11 NP_443099.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NALCNENST00000251127.11 linkc.2305C>T p.His769Tyr missense_variant Exon 20 of 44 1 NM_052867.4 ENSP00000251127.6

Frequencies

GnomAD3 genomes
AF:
0.0185
AC:
2813
AN:
152158
Hom.:
22
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00485
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0128
Gnomad ASJ
AF:
0.0415
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00683
Gnomad FIN
AF:
0.0171
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0295
Gnomad OTH
AF:
0.0205
GnomAD2 exomes
AF:
0.0199
AC:
5001
AN:
251062
AF XY:
0.0203
show subpopulations
Gnomad AFR exome
AF:
0.00468
Gnomad AMR exome
AF:
0.00674
Gnomad ASJ exome
AF:
0.0371
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0180
Gnomad NFE exome
AF:
0.0320
Gnomad OTH exome
AF:
0.0224
GnomAD4 exome
AF:
0.0258
AC:
37694
AN:
1461528
Hom.:
580
Cov.:
31
AF XY:
0.0255
AC XY:
18565
AN XY:
727090
show subpopulations
African (AFR)
AF:
0.00400
AC:
134
AN:
33476
American (AMR)
AF:
0.00809
AC:
362
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0408
AC:
1067
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39678
South Asian (SAS)
AF:
0.00621
AC:
536
AN:
86254
European-Finnish (FIN)
AF:
0.0208
AC:
1113
AN:
53406
Middle Eastern (MID)
AF:
0.0146
AC:
84
AN:
5768
European-Non Finnish (NFE)
AF:
0.0297
AC:
33022
AN:
1111714
Other (OTH)
AF:
0.0228
AC:
1376
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.449
Heterozygous variant carriers
0
1807
3614
5420
7227
9034
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1198
2396
3594
4792
5990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0185
AC:
2812
AN:
152276
Hom.:
22
Cov.:
33
AF XY:
0.0173
AC XY:
1291
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.00484
AC:
201
AN:
41550
American (AMR)
AF:
0.0128
AC:
196
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0415
AC:
144
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00684
AC:
33
AN:
4828
European-Finnish (FIN)
AF:
0.0171
AC:
181
AN:
10608
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0296
AC:
2010
AN:
68016
Other (OTH)
AF:
0.0203
AC:
43
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
146
292
437
583
729
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0267
Hom.:
201
Bravo
AF:
0.0179
TwinsUK
AF:
0.0243
AC:
90
ALSPAC
AF:
0.0340
AC:
131
ESP6500AA
AF:
0.00726
AC:
32
ESP6500EA
AF:
0.0303
AC:
261
ExAC
AF:
0.0209
AC:
2532
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.0269
EpiControl
AF:
0.0288

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 22, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Uncertain
-0.050
CADD
Uncertain
25
DANN
Benign
0.95
DEOGEN2
Benign
0.30
T
Eigen
Uncertain
0.32
Eigen_PC
Uncertain
0.42
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.95
D
MetaRNN
Benign
0.0090
T
MetaSVM
Uncertain
0.40
D
MutationAssessor
Benign
0.90
L
PhyloP100
9.4
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
-1.9
N
REVEL
Uncertain
0.48
Sift
Benign
0.91
T
Sift4G
Benign
1.0
T
Vest4
0.34
ClinPred
0.025
T
GERP RS
5.2
Varity_R
0.22
gMVP
0.60
Mutation Taster
=79/21
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76776920; hg19: chr13-101763029; COSMIC: COSV99078453; API